ETF

INDA vs. EPI: Which India ETF Best Captures the World’s Fastest-Growing Big Economy?

Photo of John Seetoo
By John Seetoo Published

Quick Read

  • EPI has beaten INDA over every measured timeframe by weighting holdings by net income rather than market cap, returning 131% vs. 91% over ten years.

  • INDA charges 0.61% vs. EPI's 0.85% and triggers less portfolio turnover, making it the stronger pick for tax-sensitive investors in taxable accounts.

  • EPI's lower-multiple value holdings cushioned India's 2026 selloff, dropping just 9% YTD versus INDA's 10%, while also capturing more mid- and small-cap upside.

  • Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
INDA vs. EPI: Which India ETF Best Captures the World’s Fastest-Growing Big Economy?

© superbeststock / Shutterstock.com

India remains the world’s fastest-growing large economy, and two ETFs dominate the way U.S. investors buy into that story: the iShares MSCI India ETF (CBOE:INDA) and the WisdomTree India Earnings Fund (NYSEARCA:EPI). On the surface they look interchangeable. Both are unhedged rupee plays on a country where Goldman Sachs notes 65% of the population is below 35 and digital payments have tripled since June 2021. Under the hood, however, they are betting on completely different definitions of what makes an Indian company worth owning, and the gap has been worth roughly eight percentage points over the past three years.

What Each Fund Is Actually Betting On

INDA tracks the MSCI India Index, which weights large- and mid-cap Indian stocks by float-adjusted market capitalization. In practice that means Reliance Industries, HDFC Bank, Infosys, ICICI Bank, and TCS dominate the top of the fund. The implicit bet is that India’s winners keep winning, that the biggest and most liquid names capture the country’s growth, and that multinational-quality balance sheets deserve the highest weights.

EPI throws that logic out. Its underlying WisdomTree India Earnings Index only holds companies that are actually profitable, then weights each one by its net income. A mid-cap industrial or state-owned energy firm that prints real earnings gets a bigger slice than a fast-growing tech name trading at a premium multiple. EPI is a value-and-profitability bet with genuine small- and mid-cap exposure. INDA is a large-cap growth-and-quality bet.

Where the Difference Shows Up

Look at the return gap. Over the trailing three years, EPI is up 20.28% against INDA’s 12.24%. Extend to five years and EPI’s 33.39% lead widens dramatically over INDA’s 17.96%. Over ten years, EPI has returned 131.47% compared to INDA’s 90.86%.

The current drawdown tells the same story in reverse. India has been hit hard in 2026 on tariff worries and foreign outflows. INDA is down 9.99% year to date and 12.64% over the past year, while EPI is down 9.01% YTD and 11.25% on the year. Earnings-weighting has cushioned the fall because profitable value names carry lower multiples than the growth cohort dominating INDA.

The Practical Comparison

Feature INDA EPI
Index methodology MSCI India, market-cap weighted WisdomTree India Earnings, net-income weighted
Cap exposure Large and mid Large, mid, and small
Expense ratio 0.61% 0.85%
Dividend frequency Semi-annual Quarterly
3-year total return 12.24% 20.28%

INDA is cheaper, more liquid, and more tax-efficient because its market-cap methodology triggers less turnover. EPI’s earnings screen forces annual rebalancing that pushes distributions higher but drags on after-tax returns in a taxable account. Both funds carry the same core risks: single-country concentration, unhedged rupee exposure, and the geopolitical overhang from U.S. tariff policy and the India-China border. (For readers thinking bigger picture about emerging-market growth engines, our Winners You Already Missed report is worth a look.)

The Verdict

EPI is the stronger fund for most investors making this specific choice. It has beaten INDA over three, five, and ten years, held up better in the current drawdown, and gives real exposure to the mid- and small-cap segment where India’s domestic consumption story actually lives. INDA earns its place for tax-sensitive investors in taxable accounts or those who specifically want the mega-cap quality trade: Reliance, HDFC, Infosys, and TCS as a concentrated large-cap bet. What flips the calculus is a return of the growth-over-value regime that dominated 2020 and 2021. If Indian large-cap tech and financials lead the next rally, INDA’s construction will finally work in its favor.

Contact [email protected] for any questions or corrections.

Photo of John Seetoo
About the Author John Seetoo →

After 15 years on Wall Street with 7 of them as Director of Corporate and Municipal Bond Trading for a NYSE member firm, I started my own project and corporate finance consultancy. Much of the work involves writing business plans, presentations, white papers and marketing materials for companies seeking budgetary allocations for spinoffs and new initiatives or for raising capital for expansion or startup companies and entrepreneurs. On financial topics, I have been published under my own byline at The Motley Fool, 247wallst.com, DealFlow Events’ Healthcare Services Investment Newsletter and The Microcap Newsletter, among others.  Additionally, I have done freelance ghostwriting writing and editing for several financial websites, such as Seeking Alpha and Shmoop Financial. I have also written and been published on a variety of other topics from music, audiophile sound and film to musical instrument history, martial arts, and current events.  Publications include Copper Magazine, Fidelity (Germany), Blasting News, Inside Kung-Fu, and other periodicals.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

META Vol: 40,760,422
KMX Vol: 2,288,021
WY Vol: 6,523,553
SBAC Vol: 1,443,801
NVDA Vol: 148,249,982

Top Losing Stocks

MRNA Vol: 9,176,778
CTRA Vol: 73,319,495
CRWD Vol: 9,269,567
DDOG Vol: 5,135,556
EPAM Vol: 1,164,561